Table 3.
Laboratory results of patients with 2019-nCoV pneumonia
| Patients (n=99) | ||
|---|---|---|
| Blood routine | ||
| Leucocytes (× 109 per L; normal range 3·5–9·5) | 7·5 (3·6) | |
| Increased | 24 (24%) | |
| Decreased | 9 (9%) | |
| Neutrophils (× 109 per L; normal range 1·8–6·3) | 5·0 (3·3–8·1) | |
| Increased | 38 (38%) | |
| Lymphocytes (× 109 per L; normal range 1·1–3·2) | 0·9 (0·5) | |
| Decreased | 35 (35%) | |
| Platelets (× 109 per L; normal range 125·0–350·0) | 213·5 (79·1) | |
| Increased | 4 (4%) | |
| Decreased | 12 (12%) | |
| Haemoglobin (g/L; normal range 130·0–175·0) | 129·8 (14·8) | |
| Decreased | 50 (51%) | |
| Coagulation function | ||
| Activated partial thromboplastin time (s; normal range 21·0–37·0) | 27·3 (10·2) | |
| Increased | 6 (6%) | |
| Decreased | 16 (16%) | |
| Prothrombin time (s; normal range 10·5–13·5) | 11·3 (1·9) | |
| Increased | 5 (5%) | |
| Decreased | 30 (30%) | |
| D-dimer (μg/L; normal range 0·0–1·5) | 0·9 (0·5–2·8) | |
| Increased | 36 (36%) | |
| Blood biochemistry | ||
| Albumin (g/L; normal range 40·0–55·0) | 31·6 (4·0) | |
| Decreased | 97 (98%) | |
| Alanine aminotransferase (U/L; normal range 9·0–50·0) | 39·0 (22·0–53·0) | |
| Increased | 28 (28%) | |
| Aspartate aminotransferase (U/L; normal range 15·0–40·0) | 34·0 (26·0–48·0) | |
| Increased | 35 (35%) | |
| Total bilirubin (μmol/L; normal range 0·0–21·0) | 15·1 (7·3) | |
| Increased | 18 (18%) | |
| Blood urea nitrogen (mmol/L; normal range 3·6–9·5) | 5·9 (2·6) | |
| Increased | 6 (6%) | |
| Decreased | 17 (17%) | |
| Serum creatinine (μmol/L; normal range 57·0–111·0) | 75·6 (25·0) | |
| Increased | 3 (3%) | |
| Decreased | 21 (21%) | |
| Creatine kinase (U/L; normal range 50·0–310·0) | 85·0 (51·0–184·0) | |
| Increased | 13 (13%) | |
| Decreased | 23 (23%) | |
| Lactate dehydrogenase (U/L; normal range 120·0–250·0) | 336·0 (260·0–447·0) | |
| Increased | 75 (76%) | |
| Myoglobin (ng/mL; normal range 0·0–146·9) | 49·5 (32·2–99·8) | |
| Increased | 15 (15%) | |
| Glucose (mmol/L; normal range 3·9–6·1) | 7·4 (3·4) | |
| Increased | 51 (52%) | |
| Decreased | 1 (1%) | |
| Infection-related biomarkers | ||
| Procalcitonin (ng/mL; normal range 0·0–5·0) | 0·5 (1·1) | |
| Increased | 6 (6%) | |
| Interleukin-6 (pg/mL; normal range 0·0–7·0) | 7·9 (6·1–10·6) | |
| Increased | 51 (52%) | |
| Erythrocyte sedimentation rate (mm/h; normal range 0·0–15·0) | 49·9 (23·4) | |
| Increased | 84 (85%) | |
| Serum ferritin (ng/mL; normal range 21·0–274·7) | 808·7 (490·7) | |
| Increased | 62 (63%) | |
| C-reactive protein (mg/L; normal range 0·0–5·0)* | 51·4 (41·8) | |
| Increased | 63/73 (86%) | |
| Co-infection | ||
| Other viruses | 0 | |
| Bacteria | 1 (1%) | |
| Fungus | 4 (4%) | |
Data are n (%), n/N (%), mean (SD), and median (IQR). Increased means over the upper limit of the normal range and decreased means below the lower limit of the normal range. 2019-nCoV=2019 novel coronavirus.
*
Data available for 73 patients.